Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis

NCT02372383 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Ethambutol
DRUG: Rifampin
DRUG: Azithromycin
DRUG: Pancrelipase

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]